The ambient-AI-native EMR with revenue cycle built in, for independent primary care (1–5 clinicians).
Independent primary-care clinicians spend 2–3 hours every evening finishing notes, while fragmented billing leaks 5–10% of revenue and holds AR at 30–60 days. Cloud RCM suites (athenahealth, eClinicalWorks, NextGen) have outgrown this buyer on price and complexity; lower-tier EMRs ship weak interoperability and aging UX. It is the largest underserved segment in ambulatory health IT.
The 2026–2027 regulatory wave — HTI-1 enforcement (Mar 2026), USCDI v3, CMS-0057-F payer/prior-auth APIs (Jan 2027), TEFCA live with 11 QHINs — forces every incumbent to retrofit. A new entrant gets to be FHIR-native, AI-native, and TEFCA-connected from day one. This window opens roughly once a decade.
One platform with two promises: the note is done before the clinician leaves the room (structure-first ambient scribe that writes back to coded fields — problems, A/P, orders — with audio-linked evidence), and the practice is paid correctly the first time (native charge capture → 10K+ rule scrubbing → auto-posting → AI denial triage; target ≥98% first-pass clean claims, ≤32 days AR). Differentiators no incumbent ships: minute-level resource-graph scheduling, turn-key integrated RCM, and a patients-as-users data model where the record is portable and every read is audited — a compounding network moat.
athenahealth charges 4–7% of collections yet still requires the practice to hire its own billing coordinator. eClinicalWorks carries a $155M DOJ False Claims settlement and failed AI demos live. NextGen had 1.05M patient records exfiltrated in 2023 ($19.4M settlement) and couldn't produce breach-indemnity language. Elation is closest in spirit but has no integrated RCM. REV.health publishes one flat price ($399/MD-DO, $299/PA-NP, +3.5% of collections) with charting, RCM, and the ambient scribe all included.
~$26K revenue per provider per year (~$65K ACV per practice at 2.5 providers), 77% blended gross margin. RCM staffing at 0.027 FTE/PCP (derived from workload) — 95% below industry average of 0.523 and 90% below athenahealth at 0.260. Path: 5 design partners (2027) → ONC-certified GA (2028) → 650 practices and ~$35M revenue / $46M exit ARR by 2031, EBITDA-positive. High-collections specialties (ortho, cardio, GI) are a pure ACV-expansion lever after the primary-care beachhead.
De-risked before production code: a validated 10-module PRD (44 documents), full regulatory matrix across 15 frameworks, working UI prototypes, and a competitive teardown built on recorded incumbent demos. Next 90 days: close seed, sign 3–5 design-partner LOIs, first 4 engineering hires, kick off Drummond ONC + Surescripts EPCS certification (the 9–12-month critical path).
15% ownership. 12-month build period before revenue (starts ~Jun 2027). Carries the company to certified general availability and ~$2M ARR run-rate entering 2028 — the Series A milestone set.